Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease: A Prospective Post-Marketing Surveillance Study

By Chiu Pai-Yi   Dai Dao-En  

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 729-738

Adis International

Access to resources Recommend Favorite

The Efficacy and Safety of Newer Anticonvulsants in Patients with Dementia

By Dolder Christian R.   Nealy Kimberly L.  

Drugs & Aging, Vol. 29, Iss. 8, 2012-08 ,pp. : 627-637

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

By Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia

By Willan Andrew R.  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 93-106

Adis International

Access to resources Recommend Favorite

Rivastigmine in Frontotemporal Dementia: An Open-Label Study

By Rita Moretti  

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 931-937

Adis International

Access to resources Recommend Favorite